Newsletter Subject

[Can’t Miss] 1 Hour Until I Release This Hot Trade Idea

From

biotechbreakouts.com

Email Address

kyle@biotechbreakouts.com

Sent On

Mon, Dec 7, 2020 02:57 PM

Email Preheader Text

Dear Trader, Over the last few days, I’ve mentioned to you the number of catalysts not only thi

Dear Trader, Over the last few days, I’ve mentioned to you the number of catalysts not only this month, but throughout 2021. Some areas of interest include: - Biotech & Pharma - Solar & Renewable Energy - Precious Metals - Pandemic-Related Industries - Cannabis This week, there’s one major catalyst on the table… An advisory committee will meet on Dec. 10 to discuss the Emergency Use Authorization (EUA) of the Pfizer-BioNTech vaccine. It’s a major turning point in the fight against the deadly virus, and will impact a number of industries this week. This morning, I narrowed down my number one trade idea for the week, which I’ll release around 10 AM ET. [You’re going to miss out on this learning opportunity because you don’t think it’s worth $3.78 per week.]( This year, I’ve made more than $5M in trading profits, and a large portion of those gains came from trading around catalyst events.* [Right now is the perfect time to discover how to utilize catalyst events to your advantage.]( Of course, I don’t want to bombard you with information and overwhelm you. That’s why I developed this special program so you can learn some of my best techniques in bite-sized chunks. Every single week, you’ll receive my highest-conviction trade idea. That means it’s a different opportunity to learn, and it won’t be stale. Listen, I’m set to release my trade idea at 10 AM ET, so you don’t have a lot of time to make a move. [That’s why I’ve made it a no-brainer for you, and it’ll only cost $3.78 per week to get in on the action.]( Get a head start on 2021, and learn how to take advantage of all the catalysts on the table right now. Kyle Dennis RagingBull, LLC 62 Calef Hwy. #233, Lee, NH 03861 [Click Here to stop receiving emails from kyle@biotechbreakouts.com]( [Unsubscribe from all RagingBull emails]( DISCLAIMER: To more fully understand any Ragingbull.com, LLC ("RagingBull") subscription, website, application or other service ("Services"), please review our full disclaimer located at [(. FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. AnyRagingBull Service offered is for educational and informational purposes only and should NOT beconstrued as a securities-related offer or solicitation, or be relied upon as personalizedinvestment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision. RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers' trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment. RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor(IA), or IA representative with the U.S. Securities and Exchange Commission, any state securitiesregulatory authority, or any self-regulatory organization. WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services. However, Ragingbull.com, LLC, its owners, and itsemployees may purchase, sell, or hold long or short positions in securities of the companies mentioned inthis communication. If you have a current active subscription with Biotech Breakouts you will need to contact us here if you want to cancel your subscription. Opting out of emails does not remove you from your service at BiotechBreakouts.com.

Marketing emails from biotechbreakouts.com

View More
Sent On

31/07/2021

Sent On

31/07/2021

Sent On

17/07/2021

Sent On

09/07/2021

Sent On

08/07/2021

Sent On

08/07/2021

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.